These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 33278109)

  • 1. Advances in the classification and treatment of pediatric brain tumors.
    Fangusaro J; Bandopadhayay P
    Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the biology and treatment of pediatric central nervous system tumors.
    Vitanza NA; Cho YJ
    Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.
    Aboian MS; Solomon DA; Felton E; Mabray MC; Villanueva-Meyer JE; Mueller S; Cha S
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):795-800. PubMed ID: 28183840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Ependymoma.
    Vitanza NA; Partap S
    J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further understanding of the pathology of glioma: implications for the clinic.
    Camelo-Piragua S; Kesari S
    Expert Rev Neurother; 2016 Sep; 16(9):1055-65. PubMed ID: 27228211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of pediatric brain tumors.
    Biegel JA; Pollack IF
    Curr Oncol Rep; 2004 Nov; 6(6):445-52. PubMed ID: 15485613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
    Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM
    Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of paediatric central nervous system tumours.
    Chiang JC; Ellison DW
    J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
    Wood MD; Halfpenny AM; Moore SR
    Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Brain Tumors: An Update.
    Segal D; Karajannis MA
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):242-250. PubMed ID: 27230809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latest classification of ependymoma in the molecular era and advances in its treatment: a review.
    Yamaguchi J; Ohka F; Motomura K; Saito R
    Jpn J Clin Oncol; 2023 Jul; 53(8):653-663. PubMed ID: 37288489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ependymoma: Evaluation and Management Updates.
    Rudà R; Bruno F; Pellerino A; Soffietti R
    Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric glial tumors.
    Cohen KJ; Broniscer A; Glod J
    Curr Treat Options Oncol; 2001 Dec; 2(6):529-36. PubMed ID: 12057098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chromosome 1q gain in intracranial ependymomas.
    Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
    J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular predictive and prognostic factors in ependymoma.
    Benson R; Mallick S; Julka PK; Rath GK
    Neurol India; 2016; 64(2):279-86. PubMed ID: 26954807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric ependymomas: will molecular biology change patient management?
    Grill J; Bergthold G; Ferreira C
    Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.